Interferon regulatory factor-3 and its alternative splicing isoforms in tumor
10.3760/cma.j.issn.1673-422X.2017.03.010
- VernacularTitle:干扰素调节因子3及其可变剪接体与肿瘤
- Author:
Zhonghui LIU
;
Dan SUN
;
Xinmin LIU
- Keywords:
Interferon regulatory factor-3;
Spliceosomes;
Neoplasms
- From:
Journal of International Oncology
2017;44(3):196-200
- CountryChina
- Language:Chinese
-
Abstract:
As a member of interferon regulatory factor family (IRF),IRF3 plays an important role in triggering the expression of type Ⅰ interferons and downstream interferon-stimulated genes,contributing to many biological process.Researches have found that it plays an anti-oncogene role in inhibiting tumor proliferation and migration,inducing cell apoptosis.The mechanism involves in tumor immunity and inflammatory reaction,apoptosis and epithelial mesenchymal transition.The alternative splicing isoforms of IRF3 act as negative modulators of IRF3 and affect tumor development progress.The recent signaling pathways and pathogenesis researches provide new ideas for early diagnosis and treatment of cancer.
